|
US4342832A
(en)
|
1979-07-05 |
1982-08-03 |
Genentech, Inc. |
Method of constructing a replicable cloning vehicle having quasi-synthetic genes
|
|
JPS5630925A
(en)
|
1979-08-21 |
1981-03-28 |
Sumitomo Chem Co Ltd |
Purification of human growth hormone
|
|
US4671958A
(en)
|
1982-03-09 |
1987-06-09 |
Cytogen Corporation |
Antibody conjugates for the delivery of compounds to target sites
|
|
EP0307434B2
(en)
|
1987-03-18 |
1998-07-29 |
Scotgen Biopharmaceuticals, Inc. |
Altered antibodies
|
|
US6710169B2
(en)
|
1987-10-02 |
2004-03-23 |
Genentech, Inc. |
Adheson variants
|
|
US4952394A
(en)
|
1987-11-23 |
1990-08-28 |
Bristol-Myers Company |
Drug-monoclonal antibody conjugates
|
|
US5981485A
(en)
|
1997-07-14 |
1999-11-09 |
Genentech, Inc. |
Human growth hormone aqueous formulation
|
|
GB8824869D0
(en)
|
1988-10-24 |
1988-11-30 |
Stevenson G T |
Synthetic antibody
|
|
US5681566A
(en)
|
1988-10-24 |
1997-10-28 |
3I Research Exploitation Limited |
Antibody conjugates with two or more covalently linked FC regions
|
|
US5225538A
(en)
|
1989-02-23 |
1993-07-06 |
Genentech, Inc. |
Lymphocyte homing receptor/immunoglobulin fusion proteins
|
|
US5208020A
(en)
|
1989-10-25 |
1993-05-04 |
Immunogen Inc. |
Cytotoxic agents comprising maytansinoids and their therapeutic use
|
|
CS89491A3
(en)
|
1990-04-09 |
1992-01-15 |
Chugai Pharmaceutical Co Ltd |
Hybrid calcitonin
|
|
RU2145233C1
(ru)
*
|
1990-07-02 |
2000-02-10 |
Дзе Аризона Борд оф Риджентс |
Неупорядоченная библиотека пептидов, способ ее получения и способ идентификации пептида, синтезированного твердофазным синтезом
|
|
DE69231467T2
(de)
|
1991-05-10 |
2001-01-25 |
Genentech, Inc. |
Auswählen von agonisten und antagonisten von liganden
|
|
US6329509B1
(en)
|
1991-08-14 |
2001-12-11 |
Genentech, Inc. |
Anti-IgE antibodies
|
|
SK279641B6
(sk)
|
1991-12-20 |
1999-01-11 |
Novo Nordisk A/S |
Stabilizovaný farmaceutický prípravok obsahujúci r
|
|
FR2686899B1
(fr)
|
1992-01-31 |
1995-09-01 |
Rhone Poulenc Rorer Sa |
Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
|
|
CA2076465C
(en)
|
1992-03-25 |
2002-11-26 |
Ravi V. J. Chari |
Cell binding agent conjugates of analogues and derivatives of cc-1065
|
|
US5686072A
(en)
|
1992-06-17 |
1997-11-11 |
Board Of Regents, The University Of Texas |
Epitope-specific monoclonal antibodies and immunotoxins and uses thereof
|
|
US6284727B1
(en)
|
1993-04-07 |
2001-09-04 |
Scios, Inc. |
Prolonged delivery of peptides
|
|
US5359030A
(en)
|
1993-05-10 |
1994-10-25 |
Protein Delivery, Inc. |
Conjugation-stabilized polypeptide compositions, therapeutic delivery and diagnostic formulations comprising same, and method of making and using the same
|
|
US5484892A
(en)
|
1993-05-21 |
1996-01-16 |
Dana-Farber Cancer Institute, Inc. |
Monoclonal antibodies that block ligand binding to the CD22 receptor in mature B cells
|
|
US5885573A
(en)
|
1993-06-01 |
1999-03-23 |
Arch Development Corporation |
Methods and materials for modulation of the immunosuppressive activity and toxicity of monoclonal antibodies
|
|
AU3272695A
(en)
|
1994-08-12 |
1996-03-07 |
Immunomedics Inc. |
Immunoconjugates and humanized antibodies specific for b-cell lymphoma and leukemia cells
|
|
US5731168A
(en)
|
1995-03-01 |
1998-03-24 |
Genentech, Inc. |
Method for making heteromultimeric polypeptides
|
|
US5698672A
(en)
|
1995-04-04 |
1997-12-16 |
Zymogenetics, Inc. |
Synthetic calcitonin mimetics
|
|
US6121022A
(en)
|
1995-04-14 |
2000-09-19 |
Genentech, Inc. |
Altered polypeptides with increased half-life
|
|
JP3871713B2
(ja)
|
1995-05-10 |
2007-01-24 |
協和醗酵工業株式会社 |
新規毒素複合体
|
|
ATE247488T1
(de)
|
1995-10-13 |
2003-09-15 |
Us Gov Health & Human Serv |
Immunotoxin enthaltend ein disulfid- stabilisiertes antikörperfragment
|
|
ATE267610T1
(de)
|
1996-03-20 |
2004-06-15 |
Immunomedics Inc |
Glykosylierte igg antikörper
|
|
US6268343B1
(en)
|
1996-08-30 |
2001-07-31 |
Novo Nordisk A/S |
Derivatives of GLP-1 analogs
|
|
US6653104B2
(en)
|
1996-10-17 |
2003-11-25 |
Immunomedics, Inc. |
Immunotoxins, comprising an internalizing antibody, directed against malignant and normal cells
|
|
PT1629849E
(pt)
|
1997-01-07 |
2013-07-09 |
Amylin Pharmaceuticals Llc |
Composições farmacêuticas que compreendem exendinas e seus agonistas
|
|
US6548644B1
(en)
|
1997-03-10 |
2003-04-15 |
Immunex Corporation |
Site protected protein modification
|
|
DE69838979T2
(de)
|
1997-03-20 |
2008-12-24 |
The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services |
Rekombinante antikörper und immunkonjugate gezielt auf cd22-tragende zellen und tumoren
|
|
US6183744B1
(en)
|
1997-03-24 |
2001-02-06 |
Immunomedics, Inc. |
Immunotherapy of B-cell malignancies using anti-CD22 antibodies
|
|
JP2002510193A
(ja)
|
1997-03-31 |
2002-04-02 |
イーライ・リリー・アンド・カンパニー |
グルカゴン様ペプチド−１類似体
|
|
CN1269805A
(zh)
|
1997-07-14 |
2000-10-11 |
博尔德生物技术公司 |
生长激素和相关蛋白的衍生物
|
|
WO1999043708A1
(en)
|
1998-02-27 |
1999-09-02 |
Novo Nordisk A/S |
Glp-1 derivatives of glp-1 and exendin with protracted profile of action
|
|
US6194551B1
(en)
|
1998-04-02 |
2001-02-27 |
Genentech, Inc. |
Polypeptide variants
|
|
US6528624B1
(en)
|
1998-04-02 |
2003-03-04 |
Genentech, Inc. |
Polypeptide variants
|
|
GB9809951D0
(en)
|
1998-05-08 |
1998-07-08 |
Univ Cambridge Tech |
Binding molecules
|
|
US6803451B2
(en)
|
1998-09-23 |
2004-10-12 |
Zymogenetics, Inc. |
Cytokine receptor zalpha11 polypeptides
|
|
US6576744B1
(en)
|
1998-09-23 |
2003-06-10 |
Zymogenetics, Inc. |
Cytokine receptor zalpha11
|
|
US6660843B1
(en)
|
1998-10-23 |
2003-12-09 |
Amgen Inc. |
Modified peptides as therapeutic agents
|
|
US7488590B2
(en)
|
1998-10-23 |
2009-02-10 |
Amgen Inc. |
Modified peptides as therapeutic agents
|
|
US7425541B2
(en)
|
1998-12-11 |
2008-09-16 |
Medarex, Inc. |
Enzyme-cleavable prodrug compounds
|
|
US6737056B1
(en)
|
1999-01-15 |
2004-05-18 |
Genentech, Inc. |
Polypeptide variants with altered effector function
|
|
US7183387B1
(en)
|
1999-01-15 |
2007-02-27 |
Genentech, Inc. |
Polypeptide variants with altered effector function
|
|
KR100940380B1
(ko)
|
1999-01-15 |
2010-02-02 |
제넨테크, 인크. |
효과기 기능이 변화된 폴리펩티드 변이체
|
|
US6897044B1
(en)
|
1999-01-28 |
2005-05-24 |
Biogen Idec, Inc. |
Production of tetravalent antibodies
|
|
US7258869B1
(en)
|
1999-02-08 |
2007-08-21 |
Alza Corporation |
Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle
|
|
US6307024B1
(en)
|
1999-03-09 |
2001-10-23 |
Zymogenetics, Inc. |
Cytokine zalpha11 Ligand
|
|
US6395226B1
(en)
|
1999-04-06 |
2002-05-28 |
Medtronic, Inc. |
Alkoxysilane/alkysilane copolymer coating of medical devices
|
|
DE19926475A1
(de)
|
1999-06-10 |
2000-12-14 |
Ktb Tumorforschungs Gmbh |
Träger-Pharmaka-Konjugate
|
|
CA2385528C
(en)
|
1999-10-01 |
2013-12-10 |
Immunogen, Inc. |
Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
|
|
US6824780B1
(en)
|
1999-10-29 |
2004-11-30 |
Genentech, Inc. |
Anti-tumor antibody compositions and methods of use
|
|
CA2393369A1
(en)
|
1999-12-03 |
2001-06-07 |
Zymogenetics, Inc. |
Human cytokine receptor
|
|
CA2400034A1
(en)
|
2000-02-17 |
2001-08-23 |
Incyte Genomics, Inc. |
Human kinases
|
|
US6570040B2
(en)
|
2000-03-16 |
2003-05-27 |
The Regents Of The University Of California |
Chemoselective ligation
|
|
US7097840B2
(en)
|
2000-03-16 |
2006-08-29 |
Genentech, Inc. |
Methods of treatment using anti-ErbB antibody-maytansinoid conjugates
|
|
DE60125543T2
(de)
|
2000-04-05 |
2007-10-04 |
Zymogenetics, Inc., Seattle |
Löslicher zytokinrezeptor zalpha11
|
|
US6756480B2
(en)
|
2000-04-27 |
2004-06-29 |
Amgen Inc. |
Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
|
|
AU2001273983A1
(en)
|
2000-05-02 |
2001-11-12 |
Lutz F. Tietze |
Novel prodrugs von 6-hydroxy-2,3-dihydro-1h-indoles, 5-hydroxy-1,2-dihydro-3h-pyrrolo(3,2-e)indoles and 5-hydroxy-1,2-dihydro-3h-benzo(e)indoles as well as of 6-hydroxy-1,2,3,4-tetrahydro-benzo(f)quinoline derivatives for use in selective cancer therapy
|
|
AU2001264946A1
(en)
|
2000-05-24 |
2001-12-03 |
Imclone Systems Incorporated |
Bispecific immunoglobulin-like antigen binding proteins and method of production
|
|
US7214663B2
(en)
|
2000-06-14 |
2007-05-08 |
Medarex, Inc. |
Tripeptide prodrug compounds
|
|
AU2001266853B2
(en)
|
2000-06-14 |
2005-02-17 |
Medarex, Inc. |
Prodrug compounds with an oligopeptide having an isoleucine residue
|
|
EP2177616B1
(en)
|
2000-08-08 |
2012-02-29 |
ZymoGenetics, Inc. |
Soluble zcytor 11 cytokine receptors
|
|
US7402556B2
(en)
|
2000-08-24 |
2008-07-22 |
Medarex, Inc. |
Prodrugs activated by plasmin and their use in cancer chemotherapy
|
|
US7118737B2
(en)
|
2000-09-08 |
2006-10-10 |
Amylin Pharmaceuticals, Inc. |
Polymer-modified synthetic proteins
|
|
US20020128448A1
(en)
*
|
2000-10-20 |
2002-09-12 |
Idec Pharmaceuticals Corporation |
Variant IgG3 Rituxan and therapeutic use thereof
|
|
JP2004516826A
(ja)
|
2000-11-07 |
2004-06-10 |
ザイモジェネティクス，インコーポレイティド |
ヒト腫瘍壊死因子受容体
|
|
GB0029154D0
(en)
|
2000-11-30 |
2001-01-17 |
Lee Helen |
Signal enhancement with multiple labelled-antibodies
|
|
ES2311560T3
(es)
|
2000-12-07 |
2009-02-16 |
Eli Lilly And Company |
Proteinas de fusion glp-1.
|
|
WO2002070655A2
(en)
|
2001-03-02 |
2002-09-12 |
Zymogenetics, Inc. |
Mouse cytokine receptor
|
|
EP1383492A4
(en)
|
2001-03-23 |
2008-12-24 |
Napro Biotherapeutics Inc |
MOLECULAR CONJUGATES FOR USE IN CANCER THERAPY
|
|
CA2439961A1
(en)
|
2001-03-27 |
2002-10-03 |
Zymogenetics, Inc. |
Human cytokine receptor
|
|
IL158418A0
(en)
|
2001-04-19 |
2004-05-12 |
Scripps Research Inst |
In vivo incorporation of unnatural amino acids
|
|
US7256257B2
(en)
|
2001-04-30 |
2007-08-14 |
Seattle Genetics, Inc. |
Pentapeptide compounds and uses related thereto
|
|
US6884869B2
(en)
|
2001-04-30 |
2005-04-26 |
Seattle Genetics, Inc. |
Pentapeptide compounds and uses related thereto
|
|
US6608196B2
(en)
|
2001-05-03 |
2003-08-19 |
Galileo Pharmaceuticals, Inc. |
Process for solid supported synthesis of pyruvate-derived compounds
|
|
US20030013656A1
(en)
|
2001-05-03 |
2003-01-16 |
Bing Wang |
Pyruvate derivatives
|
|
US20030103985A1
(en)
|
2001-05-18 |
2003-06-05 |
Boehringer Ingelheim International Gmbh |
Cytotoxic CD44 antibody immunoconjugates
|
|
US6978243B2
(en)
|
2001-05-22 |
2005-12-20 |
International Flavors & Fragrances Inc. |
Method for the analysis of sensory perception
|
|
EA010594B1
(ru)
|
2001-05-24 |
2008-10-30 |
Займодженетикс, Инк. |
Слитые белки taci-иммуноглобулина
|
|
US6441163B1
(en)
|
2001-05-31 |
2002-08-27 |
Immunogen, Inc. |
Methods for preparation of cytotoxic conjugates of maytansinoids and cell binding agents
|
|
US7087600B2
(en)
|
2001-05-31 |
2006-08-08 |
Medarex, Inc. |
Peptidyl prodrugs and linkers and stabilizers useful therefor
|
|
JP4619651B2
(ja)
|
2001-06-01 |
2011-01-26 |
コーネル・リサーチ・ファンデーション・インコーポレイテッド |
前立腺特異的膜抗原に対する修飾抗体およびその使用
|
|
US7803915B2
(en)
|
2001-06-20 |
2010-09-28 |
Genentech, Inc. |
Antibody compositions for the diagnosis and treatment of tumor
|
|
US7321026B2
(en)
|
2001-06-27 |
2008-01-22 |
Skytech Technology Limited |
Framework-patched immunoglobulins
|
|
US7176278B2
(en)
|
2001-08-30 |
2007-02-13 |
Biorexis Technology, Inc. |
Modified transferrin fusion proteins
|
|
US20030109682A1
(en)
|
2001-09-07 |
2003-06-12 |
Daniel Santi |
Maytansines and maytansine conjugates
|
|
US6770625B2
(en)
|
2001-09-07 |
2004-08-03 |
Nobex Corporation |
Pharmaceutical compositions of calcitonin drug-oligomer conjugates and methods of treating diseases therewith
|
|
US7091186B2
(en)
|
2001-09-24 |
2006-08-15 |
Seattle Genetics, Inc. |
p-Amidobenzylethers in drug delivery agents
|
|
CA2461351C
(en)
|
2001-09-26 |
2014-08-05 |
Ira H. Pastan |
Mutated anti-cd22 antibodies with increased affinity to cd22-expressing leukemia cells
|
|
US6864069B2
(en)
|
2001-10-05 |
2005-03-08 |
Bayer Pharmaceuticals Corporation |
Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use
|
|
EP2042196B1
(en)
|
2001-10-10 |
2016-07-13 |
ratiopharm GmbH |
Remodelling and glycoconjugation of Granulocyte Colony Stimulating Factor (G-CSF)
|
|
KR100988949B1
(ko)
|
2001-10-25 |
2010-10-20 |
제넨테크, 인크. |
당단백질 조성물
|
|
US20030171285A1
(en)
|
2001-11-20 |
2003-09-11 |
Finn Rory F. |
Chemically-modified human growth hormone conjugates
|
|
US6716821B2
(en)
|
2001-12-21 |
2004-04-06 |
Immunogen Inc. |
Cytotoxic agents bearing a reactive polyethylene glycol moiety, cytotoxic conjugates comprising polyethylene glycol linking groups, and methods of making and using the same
|
|
PT1463751E
(pt)
|
2001-12-21 |
2013-08-26 |
Human Genome Sciences Inc |
Proteínas de fusão de albumina
|
|
GB0130947D0
(en)
|
2001-12-24 |
2002-02-13 |
Lee Helen |
Improved sample preparation for the detection of infectious agents
|
|
DE60334364D1
(de)
|
2002-02-21 |
2010-11-11 |
Univ California |
Behandlungsverfahren unter verwendung von anti-cd22-antikörpern
|
|
US20090042291A1
(en)
|
2002-03-01 |
2009-02-12 |
Xencor, Inc. |
Optimized Fc variants
|
|
US20100311954A1
(en)
|
2002-03-01 |
2010-12-09 |
Xencor, Inc. |
Optimized Proteins that Target Ep-CAM
|
|
AU2003217912A1
(en)
|
2002-03-01 |
2003-09-16 |
Xencor |
Antibody optimization
|
|
US20070148171A1
(en)
|
2002-09-27 |
2007-06-28 |
Xencor, Inc. |
Optimized anti-CD30 antibodies
|
|
US20080219974A1
(en)
|
2002-03-01 |
2008-09-11 |
Bernett Matthew J |
Optimized antibodies that target hm1.24
|
|
US20080199471A1
(en)
|
2002-03-01 |
2008-08-21 |
Bernett Matthew J |
Optimized cd40 antibodies and methods of using the same
|
|
US20080152649A1
(en)
|
2002-03-01 |
2008-06-26 |
Xencor, Inc. |
Optimized igf-1r antibodies and methods of using the same
|
|
US20090162382A1
(en)
|
2002-03-01 |
2009-06-25 |
Bernett Matthew J |
Optimized ca9 antibodies and methods of using the same
|
|
US20080206242A1
(en)
|
2002-03-01 |
2008-08-28 |
Xencor, Inc. |
Method of treatment of th2-mediated conditions using optimized anti-cd30 antibodies
|
|
US20080260731A1
(en)
|
2002-03-01 |
2008-10-23 |
Bernett Matthew J |
Optimized antibodies that target cd19
|
|
US20080254027A1
(en)
|
2002-03-01 |
2008-10-16 |
Bernett Matthew J |
Optimized CD5 antibodies and methods of using the same
|
|
US7662925B2
(en)
|
2002-03-01 |
2010-02-16 |
Xencor, Inc. |
Optimized Fc variants and methods for their generation
|
|
US8188231B2
(en)
|
2002-09-27 |
2012-05-29 |
Xencor, Inc. |
Optimized FC variants
|
|
US20040132101A1
(en)
|
2002-09-27 |
2004-07-08 |
Xencor |
Optimized Fc variants and methods for their generation
|
|
BR0308090A
(pt)
|
2002-03-01 |
2006-04-11 |
Univ Tulane |
conjugados de agentes citotóxicos ou terapêuticos e peptìdios biologicamente ativos
|
|
US7317091B2
(en)
|
2002-03-01 |
2008-01-08 |
Xencor, Inc. |
Optimized Fc variants
|
|
US6756397B2
(en)
|
2002-04-05 |
2004-06-29 |
Immunogen, Inc. |
Prodrugs of CC-1065 analogs
|
|
GB0210121D0
(en)
|
2002-05-02 |
2002-06-12 |
Celltech R&D Ltd |
Biological products
|
|
JP4524181B2
(ja)
|
2002-05-30 |
2010-08-11 |
マクロジェニクス，インコーポレーテッド |
Ｃｄ１６ａ結合タンパク質および免疫障害治療のための使用
|
|
EP1551453A4
(en)
|
2002-06-17 |
2007-04-25 |
Us Gov Health & Human Serv |
SPECIFICITY GRAFTING OF A MICE RESPONSE TO A HUMAN FRAME
|
|
ES2544527T3
(es)
|
2002-07-31 |
2015-09-01 |
Seattle Genetics, Inc. |
Conjugados de fármacos y su uso para tratar el cáncer, una enfermedad autoinmune o una enfermedad infecciosa
|
|
ES2361739T3
(es)
|
2002-08-16 |
2011-06-21 |
Immunogen, Inc. |
Reticulantes con elevada reactividad y solubilidad y su uso en la preparación de conjugados para el suministro dirigido de fármacos de molécula pequeña.
|
|
US7189811B2
(en)
|
2002-09-06 |
2007-03-13 |
National Institute Of Immunology |
Process for solubilization of recombinant proteins expressed as inclusion body
|
|
US20060235208A1
(en)
|
2002-09-27 |
2006-10-19 |
Xencor, Inc. |
Fc variants with optimized properties
|
|
MXPA05003978A
(es)
|
2002-10-16 |
2005-06-22 |
Scripps Research Inst |
Sintesis de glicoproteinas.
|
|
US7534427B2
(en)
|
2002-12-31 |
2009-05-19 |
Immunomedics, Inc. |
Immunotherapy of B cell malignancies and autoimmune diseases using unconjugated antibodies and conjugated antibodies and antibody combinations and fusion proteins
|
|
EP1588166A4
(en)
|
2003-01-09 |
2007-06-27 |
Macrogenics Inc |
VECTOR SYSTEM WITH DOUBLE EXPRESSION FOR EXPRESSING ANTIBODIES IN BACTERIAL AND MAMMAL CELLS
|
|
US7960512B2
(en)
|
2003-01-09 |
2011-06-14 |
Macrogenics, Inc. |
Identification and engineering of antibodies with variant Fc regions and methods of using same
|
|
EP2368578A1
(en)
|
2003-01-09 |
2011-09-28 |
Macrogenics, Inc. |
Identification and engineering of antibodies with variant Fc regions and methods of using same
|
|
CN101444621B
(zh)
|
2003-02-11 |
2013-11-20 |
夏尔人类遗传性治疗公司 |
使用甲酰-甘氨酸生成酶(fge)对多种硫酸酯酶缺乏症和其它病症进行诊断和治疗
|
|
DK1594542T3
(da)
|
2003-02-20 |
2010-10-11 |
Seattle Genetics Inc |
Anti-CD70 antistof-lægemiddelkonjugater og deres anvendelse ved behandling af cancer
|
|
US20070275460A1
(en)
|
2003-03-03 |
2007-11-29 |
Xencor.Inc. |
Fc Variants With Optimized Fc Receptor Binding Properties
|
|
US20090010920A1
(en)
|
2003-03-03 |
2009-01-08 |
Xencor, Inc. |
Fc Variants Having Decreased Affinity for FcyRIIb
|
|
US8084582B2
(en)
|
2003-03-03 |
2011-12-27 |
Xencor, Inc. |
Optimized anti-CD20 monoclonal antibodies having Fc variants
|
|
US8388955B2
(en)
|
2003-03-03 |
2013-03-05 |
Xencor, Inc. |
Fc variants
|
|
WO2004082640A2
(en)
|
2003-03-19 |
2004-09-30 |
New Century Pharmaceuticals, Inc. |
Human serum albumin conjugates with therapeutic compounds
|
|
TWI353991B
(en)
|
2003-05-06 |
2011-12-11 |
Syntonix Pharmaceuticals Inc |
Immunoglobulin chimeric monomer-dimer hybrids
|
|
WO2004108885A2
(en)
|
2003-05-06 |
2004-12-16 |
Syntonix Pharmaceuticals, Inc. |
Fc chimeric proteins with anti-hiv drugs
|
|
ES2333598T5
(es)
|
2003-05-06 |
2013-09-04 |
Biogen Idec Hemophilia Inc |
Proteinas quimericas del factor de coagulacion fc para tratar la hemofilia.
|
|
US7374762B2
(en)
|
2003-05-14 |
2008-05-20 |
Immunogen, Inc. |
Drug conjugate composition
|
|
US7276497B2
(en)
|
2003-05-20 |
2007-10-02 |
Immunogen Inc. |
Cytotoxic agents comprising new maytansinoids
|
|
JP4629047B2
(ja)
|
2003-06-12 |
2011-02-09 |
イーライ リリー アンド カンパニー |
Ｇｌｐ−１アナログ複合タンパク質
|
|
BRPI0411475A
(pt)
|
2003-06-18 |
2006-07-25 |
Scripps Research Inst |
adições de código genético de aminoácido reativo não natural
|
|
US7700097B2
(en)
|
2003-06-27 |
2010-04-20 |
Biogen Idec Ma Inc. |
Purification and preferential synthesis of binding molecules
|
|
KR101672664B1
(ko)
*
|
2003-07-21 |
2016-11-04 |
이뮤노젠 아이엔씨 |
인간화된 항체 또는 그의 항원결정기 결합절편
|
|
US6943234B2
(en)
|
2003-07-30 |
2005-09-13 |
Zymogenetics, Inc. |
Pichia methanolica secretory signal
|
|
US20060134105A1
(en)
|
2004-10-21 |
2006-06-22 |
Xencor, Inc. |
IgG immunoglobulin variants with optimized effector function
|
|
US20070148170A1
(en)
|
2005-10-03 |
2007-06-28 |
Desjarlais John R |
Fc Variants With Optimized Fc Receptor Binding Properties
|
|
US8101720B2
(en)
|
2004-10-21 |
2012-01-24 |
Xencor, Inc. |
Immunoglobulin insertions, deletions and substitutions
|
|
AR047720A1
(es)
|
2003-09-30 |
2006-02-15 |
Bio Sidus S A |
Un proceso para la obtencion de mamiferos transgenicos que produzcan proteinas exogenas en leche y los mamiferos producidos por dicho proceso
|
|
SG176455A1
(en)
|
2003-10-09 |
2011-12-29 |
Ambrx Inc |
Polymer derivatives
|
|
EP3434275A1
(en)
|
2003-11-06 |
2019-01-30 |
Seattle Genetics, Inc. |
Assay for cancer cells based on the use of auristatin conjugates with antibodies
|
|
WO2005047337A1
(en)
|
2003-11-13 |
2005-05-26 |
Hanmi Pharmaceutical Co., Ltd. |
A pharmaceutical composition comprising an immunoglobulin fc region as a carrier
|
|
ES2343965T3
(es)
|
2003-11-25 |
2010-08-13 |
The Government Of The United States, As Represented By The Secretary Of Health And Human Services |
Anticuerpos anti-cd22 e inmunocongujados mutados.
|
|
EP1701979A2
(en)
|
2003-12-03 |
2006-09-20 |
Xencor, Inc. |
Optimized antibodies that target the epidermal growth factor receptor
|
|
JP2007512846A
(ja)
|
2003-12-04 |
2007-05-24 |
ゼンコー・インコーポレイテッド |
増加した宿主ストリング含有量を有する変異体タンパク質の生成方法およびその組成物
|
|
CA2550050A1
(en)
|
2003-12-18 |
2005-06-30 |
Novo Nordisk A/S |
Novel glp-1 analogues linked to albumin-like agents
|
|
WO2005077981A2
(en)
|
2003-12-22 |
2005-08-25 |
Xencor, Inc. |
Fc POLYPEPTIDES WITH NOVEL Fc LIGAND BINDING SITES
|
|
AU2005319099B2
(en)
|
2004-02-02 |
2010-09-16 |
Ambrx, Inc. |
Modified human growth hormone
|
|
CN103755800B
(zh)
|
2004-02-02 |
2016-02-24 |
Ambrx公司 |
经修饰的人类生长激素多肽与其用途
|
|
US7422696B2
(en)
|
2004-02-20 |
2008-09-09 |
Northwestern University |
Multicomponent nanorods
|
|
EP1718667B1
(en)
|
2004-02-23 |
2013-01-09 |
Genentech, Inc. |
Heterocyclic self-immolative linkers and conjugates
|
|
CA2558399C
(en)
|
2004-03-02 |
2015-05-19 |
Seattle Genetics, Inc. |
Partially loaded antibodies and methods of their conjugation
|
|
WO2005092925A2
(en)
|
2004-03-24 |
2005-10-06 |
Xencor, Inc. |
Immunoglobulin variants outside the fc region
|
|
US20050260711A1
(en)
|
2004-03-30 |
2005-11-24 |
Deepshikha Datta |
Modulating pH-sensitive binding using non-natural amino acids
|
|
WO2005101017A1
(en)
|
2004-04-07 |
2005-10-27 |
Genentech, Inc. |
Mass spectrometry of antibody conjugates
|
|
JP2007536932A
(ja)
|
2004-05-10 |
2007-12-20 |
マクロジェニクス，インコーポレーテッド |
ヒト化ＦｃγＲＩＩＢ特異的抗体とその利用法
|
|
US7691962B2
(en)
|
2004-05-19 |
2010-04-06 |
Medarex, Inc. |
Chemical linkers and conjugates thereof
|
|
US7517903B2
(en)
|
2004-05-19 |
2009-04-14 |
Medarex, Inc. |
Cytotoxic compounds and conjugates
|
|
MXPA06014065A
(es)
|
2004-06-01 |
2007-01-31 |
Genentech Inc |
Conjugados de droga-anticuerpo y metodos.
|
|
CN102532321B
(zh)
|
2004-06-18 |
2018-10-12 |
Ambrx公司 |
新颖抗原结合多肽和其用途
|
|
US7638299B2
(en)
|
2004-07-21 |
2009-12-29 |
Ambrx, Inc. |
Biosynthetic polypeptides utilizing non-naturally encoded amino acids
|
|
US7126393B2
(en)
|
2004-08-20 |
2006-10-24 |
Micron Technology, Inc. |
Delay circuit with reset-based forward path static delay
|
|
CA2579142A1
(en)
|
2004-09-13 |
2006-03-23 |
Macrogenics, Inc. |
Humanized antibodies against west nile virus and therapeutic and prophylactic uses thereof
|
|
ES2579805T3
(es)
|
2004-09-23 |
2016-08-16 |
Genentech, Inc. |
Anticuerpos y conjugados modificados por ingeniería genética con cisteína
|
|
US7442778B2
(en)
*
|
2004-09-24 |
2008-10-28 |
Amgen Inc. |
Modified Fc molecules
|
|
CN101061137A
(zh)
|
2004-11-09 |
2007-10-24 |
Usv有限公司 |
用于纯化人生长激素的新方法
|
|
WO2007024249A2
(en)
|
2004-11-10 |
2007-03-01 |
Macrogenics, Inc. |
Engineering fc antibody regions to confer effector function
|
|
US8367805B2
(en)
|
2004-11-12 |
2013-02-05 |
Xencor, Inc. |
Fc variants with altered binding to FcRn
|
|
US20070135620A1
(en)
|
2004-11-12 |
2007-06-14 |
Xencor, Inc. |
Fc variants with altered binding to FcRn
|
|
US8802820B2
(en)
|
2004-11-12 |
2014-08-12 |
Xencor, Inc. |
Fc variants with altered binding to FcRn
|
|
BRPI0517837A
(pt)
|
2004-11-12 |
2008-10-21 |
Xencor Inc |
variantes fc com ligação alterada a fcrn
|
|
US7255012B2
(en)
|
2004-12-01 |
2007-08-14 |
Rosemount Inc. |
Process fluid flow device with variable orifice
|
|
AU2005323106B2
(en)
|
2004-12-22 |
2010-07-29 |
Ambrx, Inc. |
Methods for expression and purification of recombinant human growth hormone
|
|
US7385028B2
(en)
|
2004-12-22 |
2008-06-10 |
Ambrx, Inc |
Derivatization of non-natural amino acids and polypeptides
|
|
NZ555425A
(en)
|
2004-12-22 |
2010-04-30 |
Ambrx Inc |
Compositions of aminoacyl-tRNA synthetase and uses thereof
|
|
KR101224781B1
(ko)
|
2004-12-22 |
2013-01-21 |
암브룩스, 인코포레이티드 |
비천연적으로 코딩된 아미노산을 포함하는 인간 성장호르몬의 조제물
|
|
ES2343746T3
(es)
|
2005-01-07 |
2010-08-09 |
Diadexus, Inc. |
Composiciones de anticuerpo ovr110 y metodos de uso.
|
|
JP5165387B2
(ja)
|
2005-02-11 |
2013-03-21 |
イムノゲン インコーポレーティッド |
安定な薬物複合体を調製するための方法
|
|
US7466406B2
(en)
|
2005-03-14 |
2008-12-16 |
Northwestern University |
Analyte detection using nanowires produced by on-wire lithography
|
|
US9963510B2
(en)
|
2005-04-15 |
2018-05-08 |
Macrogenics, Inc. |
Covalent diabodies and uses thereof
|
|
ES2707152T3
(es)
|
2005-04-15 |
2019-04-02 |
Macrogenics Inc |
Diacuerpos covalentes y usos de los mismos
|
|
WO2006133088A2
(en)
|
2005-06-03 |
2006-12-14 |
Ambrx, Inc. |
Improved human interferon molecules and their uses
|
|
WO2006132969A2
(en)
|
2005-06-03 |
2006-12-14 |
Ambrx, Inc. |
Incorporation of non-naturally encoded amino acids into proteins
|
|
JP2007037018A
(ja)
|
2005-07-29 |
2007-02-08 |
Nec Electronics Corp |
スイッチ回路
|
|
HUE029465T2
(en)
|
2005-08-10 |
2017-02-28 |
Macrogenics Inc |
Identification and engineering of antibodies with variant Fc regions and methods of using same
|
|
US8008453B2
(en)
|
2005-08-12 |
2011-08-30 |
Amgen Inc. |
Modified Fc molecules
|
|
CA2618878C
(en)
|
2005-08-18 |
2016-06-28 |
Ambrx, Inc. |
Compositions of trna and uses thereof
|
|
WO2007048127A2
(en)
|
2005-10-20 |
2007-04-26 |
The Scripps Research Institute |
Fc labeling for immunostaining and immunotargeting
|
|
CN101365679B
(zh)
|
2005-10-26 |
2012-11-14 |
梅达莱克斯公司 |
制备cc-1065类似物的方法和化合物
|
|
CN103965300A
(zh)
|
2005-11-02 |
2014-08-06 |
Ambrx公司 |
生物合成多肽融合抑制剂
|
|
SI1954710T1
(sl)
|
2005-11-08 |
2011-08-31 |
Ambrx Inc |
Pospeĺ evala za modifikacijo nenaravnih aminokislin in nenaravnih peptidov aminokislin
|
|
EP1951890A4
(en)
|
2005-11-16 |
2009-06-24 |
Ambrx Inc |
PROCESSES AND COMPOSITIONS WITH NON-NATURAL AMINO ACIDS
|
|
KR101423898B1
(ko)
|
2005-12-14 |
2014-07-28 |
암브룩스, 인코포레이티드 |
비-천연 아미노산 및 폴리펩티드를 함유하는 조성물, 비-천연 아미노산 및 폴리펩티드를 포함하는 방법, 및 비-천연 아미노산 및 폴리펩티드의 용도
|
|
EP1978989A4
(en)
|
2005-12-30 |
2009-03-18 |
Ambrx Inc |
AMINO ACIDS AND NON-NATURAL POLYPEPTIDES, COMPOSITIONS CONTAINING THEM, METHODS INVOLVING THEM AND USES THEREOF
|
|
CN101384711A
(zh)
|
2006-01-19 |
2009-03-11 |
Ambrx公司 |
具有经调节的免疫原性的非天然氨基酸多肽
|
|
US20070198996A1
(en)
|
2006-02-09 |
2007-08-23 |
Ziep Software Inc. |
System and method for driving peripheral devices
|
|
CA2638819A1
(en)
|
2006-02-10 |
2008-04-03 |
Zymogenetics, Inc. |
Soluble il-17rcx4 and methods of using in inflammation
|
|
US7750116B1
(en)
|
2006-02-18 |
2010-07-06 |
Seattle Genetics, Inc. |
Antibody drug conjugate metabolites
|
|
EP1998799B8
(en)
|
2006-03-06 |
2014-03-05 |
Medlmmune, LLC |
Humanized anti-cd22 antibodies and their use in treatment of oncology, transplantation and autoimmune disease
|
|
EP1999470A4
(en)
|
2006-03-10 |
2009-08-19 |
Macrogenics Inc |
IDENTIFICATION AND GENETIC MODIFICATION OF ANTIBODIES WITH HEAVY CHAINS OF VARIANTS AND METHODS OF USE THEREOF
|
|
CA2660592C
(en)
|
2006-05-26 |
2016-07-12 |
Macrogenics, Inc. |
Humanized fc.gamma.riib-specific antibodies and methods of use thereof
|
|
WO2007140371A2
(en)
|
2006-05-30 |
2007-12-06 |
Genentech, Inc. |
Antibodies and immunoconjugates and uses therefor
|
|
CN100388056C
(zh)
|
2006-06-02 |
2008-05-14 |
上海微电子装备有限公司 |
一种投影物镜光学系统
|
|
AU2007281876B2
(en)
|
2006-06-26 |
2013-09-05 |
Macrogenics, Inc. |
FcgammaRIIB-specific antibodies and methods of use thereof
|
|
WO2008011446A2
(en)
|
2006-07-18 |
2008-01-24 |
Centocor, Inc. |
Human glp-1 mimetibodies, compositions, methods and uses
|
|
PT2064333E
(pt)
|
2006-09-08 |
2014-06-09 |
Ambrx Inc |
Supressor híbrido arnt para células de vertebrados
|
|
WO2008030558A2
(en)
|
2006-09-08 |
2008-03-13 |
Ambrx, Inc. |
Modified human plasma polypeptide or fc scaffolds and their uses
|
|
ES2457527T3
(es)
|
2006-09-08 |
2014-04-28 |
Ambrx, Inc. |
ARNt Supresor hibrido en células de vertebrados
|
|
US20100093082A1
(en)
|
2006-09-08 |
2010-04-15 |
Ambrx, Inc. |
Site Specific Incorporation of Non-Natural Amino Acids by Vertebrate Cells
|
|
US7985783B2
(en)
*
|
2006-09-21 |
2011-07-26 |
The Regents Of The University Of California |
Aldehyde tags, uses thereof in site-specific protein modification
|
|
US20080112961A1
(en)
|
2006-10-09 |
2008-05-15 |
Macrogenics, Inc. |
Identification and Engineering of Antibodies with Variant Fc Regions and Methods of Using Same
|
|
US7476555B2
(en)
|
2006-11-15 |
2009-01-13 |
Airdio Wireless Inc. |
Method of chip manufacturing
|
|
EP2097097B1
(en)
|
2006-12-01 |
2018-05-30 |
E. R. Squibb & Sons, L.L.C. |
Antibodies, in particular human antibodies, that bind cd22 and uses thereof
|
|
WO2008140603A2
(en)
|
2006-12-08 |
2008-11-20 |
Macrogenics, Inc. |
METHODS FOR THE TREATMENT OF DISEASE USING IMMUNOGLOBULINS HAVING FC REGIONS WITH ALTERED AFFINITIES FOR FCγR ACTIVATING AND FCγR INHIBITING
|
|
WO2008077079A1
(en)
|
2006-12-18 |
2008-06-26 |
Ambrx, Inc. |
Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
|
|
JP4467557B2
(ja)
|
2006-12-25 |
2010-05-26 |
富士通株式会社 |
光スイッチング方法及び光スイッチ
|
|
AU2007341997A1
(en)
|
2006-12-28 |
2008-07-10 |
Ambrx, Inc. |
Phenazine and quinoxaline substituted amino acids and polypeptides
|
|
JP5163642B2
(ja)
*
|
2007-03-29 |
2013-03-13 |
コニカミノルタホールディングス株式会社 |
有機エレクトロルミネセンス素子
|
|
KR101476472B1
(ko)
|
2007-03-30 |
2015-01-05 |
암브룩스, 인코포레이티드 |
변형된 ｆｇｆ-21 폴리펩티드 및 그 용도
|
|
US20080244222A1
(en)
|
2007-03-30 |
2008-10-02 |
Intel Corporation |
Many-core processing using virtual processors
|
|
KR20100019467A
(ko)
|
2007-05-02 |
2010-02-18 |
암브룩스, 인코포레이티드 |
변형된 인터페론 베타 폴리펩티드 및 그의 용도
|
|
TW200902554A
(en)
|
2007-05-08 |
2009-01-16 |
Genentech Inc |
Cysteine engineered anti-MUC16 antibodies and antibody drug conjugates
|
|
AU2008260498B2
(en)
|
2007-05-30 |
2012-11-29 |
Xencor, Inc. |
Methods and compositions for inhibiting CD32b expressing cells
|
|
US8318508B2
(en)
|
2007-06-20 |
2012-11-27 |
Northwestern University |
Patterning with compositions comprising lipid
|
|
WO2009046407A2
(en)
|
2007-10-04 |
2009-04-09 |
Zymogenetics, Inc. |
B7 FAMILY MEMBER zB7H6 AND RELATED COMPOSITIONS AND METHODS
|
|
WO2009117030A2
(en)
|
2007-12-19 |
2009-09-24 |
Macrogenics, Inc. |
Improved compositions for the prevention and treatment of smallpox
|
|
US7722865B2
(en)
|
2008-01-18 |
2010-05-25 |
Biomarin Pharmaceutical Inc. |
Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof
|
|
US8729232B2
(en)
*
|
2008-03-27 |
2014-05-20 |
The Regents Of The University Of California |
Aldehyde tags, uses thereof in site-specific protein modification
|
|
US8591889B2
(en)
|
2008-04-04 |
2013-11-26 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Human monoclonal antibodies specific for CD22
|
|
AU2009262199B2
(en)
*
|
2008-06-27 |
2012-08-09 |
Amgen Inc. |
Ang-2 inhibition to treat multiple sclerosis
|
|
EP2358860A1
(en)
|
2008-11-21 |
2011-08-24 |
Corning Incorporated |
Spaced projection substrates and devices for cell culture
|
|
US9238878B2
(en)
*
|
2009-02-17 |
2016-01-19 |
Redwood Bioscience, Inc. |
Aldehyde-tagged protein-based drug carriers and methods of use
|
|
JP6162606B2
(ja)
|
2011-01-14 |
2017-07-12 |
レッドウッド バイオサイエンス， インコーポレイテッド |
アルデヒド−タグ付き免疫グロブリンポリペプチド及びその使用方法
|
|
US9310374B2
(en)
|
2012-11-16 |
2016-04-12 |
Redwood Bioscience, Inc. |
Hydrazinyl-indole compounds and methods for producing a conjugate
|
|
CN105744935B
(zh)
|
2013-11-27 |
2022-09-30 |
雷德伍德生物科技股份有限公司 |
肼基-吡咯并化合物及用于生成缀合物的方法
|
|
KR102486180B1
(ko)
|
2014-06-06 |
2023-01-11 |
레드우드 바이오사이언스 인코포레이티드 |
항-her2 항체-메이탄신 컨쥬게이트 및 이것의 사용 방법
|